Identification of replication competent murine gammaretroviruses in commonly used prostate cancer cell lines.
A newly discovered gammaretrovirus, termed XMRV, was recently reported to be present in the prostate cancer cell line CWR22Rv1. Using a combination of both immunohistochemistry with broadly-reactive murine leukemia virus (MLV) anti-sera and PCR, we determined if additional prostate cancer or other c...
Main Authors: | Karen Sandell Sfanos, Amanda L Aloia, Jessica L Hicks, David M Esopi, Jared P Steranka, Wei Shao, Silvia Sanchez-Martinez, Srinivasan Yegnasubramanian, Kathleen H Burns, Alan Rein, Angelo M De Marzo |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3117837?pdf=render |
Similar Items
-
Xenotropic Murine Leukemia Virus–related Gammaretrovirus in Respiratory Tract
by: Nicole Fischer, et al.
Published: (2010-06-01) -
Infection of xenotransplanted human cell lines by murine retroviruses: A lesson brought back to light by XMRV
by: Heidi Anne Hempel, et al.
Published: (2013-06-01) -
Sensitivity of PCR assays for murine gammaretroviruses and mouse contamination in human blood samples.
by: Li Ling Lee, et al.
Published: (2012-01-01) -
Health inequity drives disease biology to create disparities in prostate cancer outcomes
by: William G. Nelson, et al.
Published: (2022-02-01) -
Modeling Human Prostate Cancer Metastasis in Mice via Resection of Subcutaneous Allografts
by: Lauren B. Peiffer, et al.
Published: (2022-04-01)